about
Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsIntravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancerDeferasirox for managing iron overload in people with myelodysplastic syndromeNon-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancerYoga in addition to standard care for patients with haematological malignanciesYoga for haematological malignanciesExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsExtracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsPharmacological interventions for pruritus in adult palliative care patientsLateral pararectal versus transrectal stoma placement for prevention of parastomal herniationExtracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patientsDeferasirox for managing iron overload in people with thalassaemiaNon-steroidal antiandrogens compared to LHRH agonists or surgical castration therapy for advanced prostate cancerDeferasirox for managing transfusional iron overload in people with sickle cell diseaseDeferasirox for managing iron overload in people with myelodysplastic syndromePharmacological interventions for pruritus in adult palliative care patientsDeferasirox for managing iron overload in people with thalassaemiaDeferasirox for managing iron overload in patients with myelodysplastic syndromeDeferasirox for managing transfusional iron overload in people with sickle cell diseaseExtent of non-publication in cohorts of studies approved by research ethics committees or included in trial registriesInitiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study designThe efficient production of high quality evidence reviews is important for the public goodNucleolar localization of RPS19 protein in normal cells and mislocalization due to mutations in the nucleolar localization signals in 2 Diamond-Blackfan anemia patients: potential insights into pathophysiologyRibosomal protein S24 gene is mutated in Diamond-Blackfan anemiaRibosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patientsSurgery versus non-surgical management for unilateral ureteric-pelvic junction obstruction in newborns and infants less than two years of ageMethodological quality of guidelines for management of Lyme neuroborreliosis.Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysisSpecialist palliative care services for adults with advanced, incurable illness in hospital, hospice, or community settings--protocol for a systematic reviewAuthors report lack of time as main reason for unpublished research presented at biomedical conferences: a systematic reviewEvidence gaps in ENT surgery - a qualitative surveyBias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensusDissemination bias in systematic reviews of animal research: a systematic reviewThe ribosomal basis of Diamond-Blackfan Anemia: mutation and database updateScientific value of systematic reviews: survey of editors of core clinical journalsGRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tablesRandomized trials addressing a similar question are commonly published after a trial stopped early for benefit.Methods for detecting, quantifying, and adjusting for dissemination bias in meta-analysis are described.[GRADE guidelines 15: going from evidence to recommendation - determinants of a recommendation's direction and strength].
P50
Q24187102-A9CA6569-AC29-4A2D-81DE-E0CB492BE1CAQ24188295-9A9E9E47-176C-4B6F-8109-3321A2A3A2DDQ24193067-35E39CC6-7FE2-44AC-8820-406ED344160BQ24193722-78CCC09D-FD3B-410C-ADB9-7FFB7B904563Q24194030-CF94561C-6F2A-4C86-9936-25CCEEEFF457Q24198951-9A2C6CFE-EB2D-4573-BB40-4FB68064687EQ24200272-F54C94C0-2306-4378-8EA5-A854379235ACQ24200282-61F5CBDE-D5CA-471F-99F5-3FA857D5BF39Q24200648-31AA57AB-7795-4E39-A419-8C72BF8E8D45Q24202000-964B809A-9113-46E7-A600-55D25BAEC33AQ24202376-63B64A3E-AA7C-4A8C-8721-A7989FF7A728Q24202963-9E817DCD-A034-41AA-899F-5EC111E505D1Q24203718-1092168B-017D-4E6E-BBC0-8A34A4209CEDQ24235190-1DCF5EC5-6C9F-45AA-8A08-D8D638A0CDD4Q24236463-CE00F33A-6965-466F-BC0C-6404D0D385CAQ24236532-D8683880-0B28-4DAE-89E9-8549DF649196Q24241586-F5887929-81B8-4FE5-B6EB-6CE91A71D26AQ24241753-6061E0BD-FFDC-4808-852A-09A853854A57Q24242437-6A239497-DD6A-419E-9F37-2F983ACF0170Q24242535-788E3503-1EDD-49BD-892C-09A0F4F186ADQ24288672-B8CDEFEF-3ACD-4223-A014-9F15C17F4BCAQ24288919-2B6E65DE-044D-46E1-B79B-5598C045974AQ24289044-23617781-6A85-42FF-B4C8-7988513BD493Q24294692-67052431-72DF-42C0-AF8B-AF7071B1E2E8Q24337910-E5DB2BFF-860C-4C59-93B1-6510A05B9988Q24643416-FA0E88A5-F7F5-4851-BC6D-FA68A8AEDF75Q26471101-C9AE458A-9AA3-4700-BCA0-7E4FF1779866Q26775435-91ADB6FC-0DA2-421E-8CE0-C69C12198995Q26777150-D5919014-DF2A-4412-B29A-A1328235BA27Q26781045-EC89CB94-E443-4454-B066-818396BE2B34Q26996522-26972E39-304F-49C2-A7E9-1BD4934A9DC9Q28071843-A2F22115-0863-48E4-A8F7-D07C8AC5A018Q28074141-7E24D777-58A3-4CD3-9B69-AFE53790A0DCQ28080709-D383C357-5E24-4629-BDB6-63DEF8BA3FD6Q28296164-4AB65849-FA84-4600-A765-53CD66FF9EAEQ28730181-791EB953-04FD-4FA5-B49D-59901DCD7D4EQ29547885-1FD1BDEE-7970-474E-B7CE-644E22B8D2DFQ30241469-9AC6B5FC-4611-46C2-B94D-3C9AED279E4CQ30248570-AD3C55B3-8B65-4E27-804B-57FDBDAD1FF6Q30316948-EB5FC33C-71CE-4133-BF04-84778D9AA538
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Joerg J Meerpohl
@ast
Joerg J Meerpohl
@en
Joerg J Meerpohl
@es
Joerg J Meerpohl
@nl
Joerg J Meerpohl
@sl
type
label
Joerg J Meerpohl
@ast
Joerg J Meerpohl
@en
Joerg J Meerpohl
@es
Joerg J Meerpohl
@nl
Joerg J Meerpohl
@sl
prefLabel
Joerg J Meerpohl
@ast
Joerg J Meerpohl
@en
Joerg J Meerpohl
@es
Joerg J Meerpohl
@nl
Joerg J Meerpohl
@sl
P214
P227
P101
P1053
J-4224-2013
P106
P21
P214
P227
P31
P3829
P3835
joerg-meerpohl1
P496
0000-0002-1333-5403
P569
1973-01-01T00:00:00Z
P7859
viaf-30409364